Killing and mutation of human lymphoblast cells by aflatoxin B1: evidence for an inducible repair response.

No abstract is available for this paper.

• Publication year

  1987

• Venue

  Cancer Research

• Publication date

  1987-04-15

• Fields of study

  Biology, Medicine, Environmental Science

• Identifiers
  PMID 3103909
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Internal standards for survival: increasing the accuracy for human cell mutation assays.

  1987cited by this paper
• Apurinic sites as mutagenic intermediates.

  1985cited by this paper
• Apurinic sites as mutagenic intermediates

  1985cited by this paper
• Cytotoxicity and mutagenicity of aflatoxin dichloride in normal and repair deficient diploid human fibroblasts.

  1984cited by this paper
• Analysis of chemically induced mutation in single cell populations.

  1983cited by this paper
• Base substitution mutations induced by metabolically activated aflatoxin B1.

  1983cited by this paper
• Ultraviolet light-induced mutation of diploid human lymphoblasts.

  1983cited by this paper
• Mutation of human lymphoblasts exposed to low concentrations of chemical mutagens for long periods of time.

  1983cited by this paper
• Characterisation of the imidazole ring-opened forms of trans-8,9-dihydro-8,9-dihydro-8-(7-guanyl)9-hydroxy aflatoxin B1.

  1982cited by this paper
• Mutation assay at the thymidine kinase locus in diploid human lymphoblasts.

  1982cited by this paper
• Production of monoclonal antibodies to guanine imidazole ring-opened aflatoxin B1DNA, the persistent DNA adduct in vivo.

  1982cited by this paper
• Characterisation of the imidazole ring-opened forms of trans-8,9-di-hydro-8-(7-guanyl)9-hydroxy aflatoxin B1

  1982cited by this paper
• In vitro reactions of aflatoxin B1-adducted DNA.

  1981cited by this paper
• Excision repair of aflatoxin B1-DNA adducts in human fibroblasts.

  1981cited by this paper
• Banbury report 2—Mammalian cell mutagenesis: The maturation of test systems.

  1981cited by this paper
• Quantitative comparison of covalent aflatoxin-DNA adducts formed in rat and mouse livers and kidneys.

  1981cited by this paper
• Quantitative Comparison of Formed in Rat and Mouse Covalent Aflatoxin-DNA Livers and Kidneys

  1981cited by this paper
• Quantitative assay for mutation in diploid human lymphoblasts using microtiter plates.

  1981cited by this paper
• Investigation of covalent aflatoxin B1-DNA adducts formed in vivo in rainbow trout (Salmo gairdneri) embryos and liver.

  1980cited by this paper
• Gene-Locus Mutation Assays in Diploid Human Lymphoblast Lines

  1980cited by this paper
• Spontaneous reactions of aflatoxin B1 modified deoxyribonucleic acid in vitro.

  1980cited by this paper
• Metabolism of aflatoxin B1 and identification of the major aflatoxin B1-DNA adducts formed in cultured human bronchus and colon.

  1979cited by this paper
• Formation and removal of aflatoxin B1-induced DNA lesions in epithelioid human lung cells.

  1979cited by this paper
• Relative sensitivities of forward and reverse mutation assays in Salmonella typhimurium.

  1978cited by this paper
• Identification of the principal aflatoxin B1-DNA adduct formed in vivo in rat liver.

  1978cited by this paper
• Isolation of a human lymphoblastoid line heterozygous at the thymidine kinase locus: possibility for a rapid human cell mutation assay.

  1978cited by this paper
• Structural identification of the major DNA adduct formed by aflatoxin B1 in vitro.

  1977cited by this paper
• 2,3-Dihydro-2-(guan-7-yl)-3-hydroxy-aflatoxin B1, a major acid hydrolysis product of aflatoxin B1-DNA or -ribosomal RNA adducts formed in hepatic microsome-mediated reactions and in rat liver in vivo.

  1977cited by this paper
• Chemical carcinogens

  1977cited by this paper
• Reduced DNA repair capacity and increased cytotoxicity following split doses of the mutagen 4-nitroquinoline-1-oxide in cultured human cells.

  1975cited by this paper
• Detection of carcinogens as mutagens in the Salmonella/microsome test: assay of 300 chemicals.

  1975cited by this paper
• Cytotoxicity and mutagenicity of ultraviolet irradiation as a function of the interval between split doses in cultured Chinese hamster cells.

  1973cited by this paper
• Induction of Mutations in DNA-repair Deficient Bacteria by a Liver Microsomal Metabolite of Aflatoxin B1

  1973cited by this paper
• Carcinogens are mutagens: a simple test system combining liver homogenates for activation and bacteria for detection.

  1973cited by this paper
• Rate of depurination of native deoxyribonucleic acid.

  1972cited by this paper
• Responses of synchronous populations of HeLa cells to ultraviolet irradiation at selected stages of the generation cycle.

  1967cited by this paper
• A procedure for the isolation of deoxyribonucleic acid from micro-organisms

  1961cited by this paper

• Inflammation as a Cancer Co-Initiator: New Mechanistic Model Predicts Low/Negligible Risk at Noninflammatory Carcinogen Doses

  2019cites this paper
• Chemical Biology of N5-Substituted Formamidopyrimidine DNA Adducts.

  2017cites this paper
• Complete Protection against Aflatoxin B1-Induced Liver Cancer with a Triterpenoid: DNA Adduct Dosimetry, Molecular Signature, and Genotoxicity Threshold

  2014cites this paper
• Dose-dependent transitions in mechanisms of toxicity and risk assessment in toxicology Dependência da dosagem nos mecanismos de toxicidade e avaliação de risco em toxicologia

  2013cites this paper
• Dietary modulation of the biotransformation and genotoxicity of aflatoxin B(1).

  2012cites this paper
• A new mouse model to probe the role of aflatoxin B 1 in liver carcinogenesis

  2011cites this paper
• Transgenic expression of aflatoxin aldehyde reductase (AKR7A1) modulates aflatoxin B1 metabolism but not hepatic carcinogenesis in the rat.

  2009cites this paper
• Protection against aflatoxin B1-induced cytotoxicity by expression of the cloned aflatoxin B1-aldehyde reductases rat AKR7A1 and human AKR7A3.

  2008cites this paper
• DNA Adduci Formation in Mouse Tissues in Relation to Serum Levels of Benzo(fl)pyrene-diol-epoxide after Injection of Benzo(a)pyrene or the Diol-epoxide1

  2006cites this paper
• Unraveling the aflatoxin-FAPY conundrum: structural basis for differential replicative processing of isomeric forms of the formamidopyrimidine-type DNA adduct of aflatoxin B1.

  2006cites this paper
• Aflatoxin Cause DNA Damage

  2004cites this paper
• Dose-dependent transitions in mechanisms of toxicity.

  2004cites this paper
• Effects of aflatoxin B1 on the development of the bursa of Fabricius and blood lymphocyte acid phosphatase of the chicken

  2003cites this paper
• 32P-post-labelling analysis of DNA adducts formed by aristolochic acid in tissues from patients with Chinese herbs nephropathy.

  1997cites this paper
• Extended Abstracts

  1997influential citation
• Mutational properties of the primary aflatoxin B1-DNA adduct.

  1996cites this paper
• A viral genome containing an unstable aflatoxin B1-N7-guanine DNA adduct situated at a unique site.

  1996cites this paper
• Mutagenesis by the primary aflatoxin B₁ DNA adduct in Escherichia coli

  1996cites this paper
• 5‐Azacytidine‐induced 6‐thioguanine resistance at the gpt locus in AS52 cells: Cellular response

  1996cites this paper
• Aflatoxin, Its Metabolism and Carcinogenesis - A Historical Review

  1994cites this paper
• Metabolism and cytotoxicity of aflatoxin B1 in cultured rat hepatocytes and nonparenchymal cells: implications for tumorigenesis.

  1994cites this paper
• Identification of the principal human cell mutagen in an organic extract of a mutagenic sediment.

  1994cites this paper
• Effect of dose and dose rate on benzo[a]pyrene induced mutational spectra in human cells

  1994cites this paper
• Effect of caloric restriction on the metabolic activation of xenobiotics.

  1993cites this paper
• Effect of caloric restriction on hepatic nuclear DNA damage in male Fischer 344 rats treated with aflatoxin B1.

  1992cites this paper
• In vivo formation of aflatoxin B1-DNA adducts in parenchymal and non-parenchymal cells of rat liver.

  1992cites this paper
• The development of a human cell line stably expressing human CYP3A4: role in the metabolic activation of aflatoxin B1 and comparison to CYP1A2 and CYP2A3.

  1991cites this paper
• Effects of Caloric Restriction on Aflatoxin B1 Metabolism and DNA Modification in Fischer 344 Rats

  1991cites this paper
• Contribution of the glutathione S-transferases to the mechanisms of resistance to aflatoxin B1.

  1991cites this paper
• Cell-cycle dependent mutation of human lymphoblasts: bromodeoxyuridine and butyl methanesulfonate.

  1991cites this paper
• The prospects of the development of the method for monitoring of occupational exposure to some alkylating agents.

  1991cites this paper
• Cytotoxicity of aflatoxin on red blood corpuscles

  1991cites this paper
• Risk assessment for aflatoxin: I. Metabolism of aflatoxin B1 by different species.

  1990cites this paper
• DNA adduct formation in mouse tissues in relation to serum levels of benzo(a)pyrene-diol-epoxide after injection of benzo(a)pyrene or the diol-epoxide.

  1990cites this paper
• Pharmacokinetic principles for dose-rate extrapolation of carcinogenic risk from genetically active agents.

  1990cites this paper
• Stable expression of human cytochrome P450IA2 cDNA in a human lymphoblastoid cell line: Role of the enzyme in the metabolic activation of aflatoxin B1

  1990cites this paper
• Comparative formation and removal of aflatoxin B1-DNA adducts in cultured mammalian tracheal epithelium.

  1990cites this paper
• Chromatographic methods as tools in the field of mycotoxins.

  1989cites this paper
• Comparison of rates of enzymatic oxidation of aflatoxin B1, aflatoxin G1, and sterigmatocystin and activities of the epoxides in forming guanyl-N7 adducts and inducing different genetic responses.

  1989cites this paper
• Depurination from DNA of 7-methylguanine, 7-(2-aminoethyl)-guanine and ring-opened 7-methylguanines.

  1989cites this paper
• DNA Adducts and Carcinogenesis

  1989cites this paper
• Long-term, low-dose benzo[a]pyrene-induced mutation in human lymphoblasts competent in xenobiotic metabolism.

  1989cites this paper
• Induction of base substitution mutations by aflatoxin B1 is mucAB dependent in Escherichia coli

  1988cites this paper
• The significance of DNA and protein adducts in human biomonitoring studies.

  1988cites this paper
• Physicochemical-viral synergism during Epstein-Barr virus infection: a review.

  1988cites this paper
• Inability of aflatoxin B1 to stimulate arachidonic acid metabolism in human polymorphonuclear and mononuclear leukocytes.

  1988cites this paper